Screening of JAK2 V617F and MPL W515 K/L negative essential thrombocythaemia patients for mutations in SESN2, DNAJC17, ST13, TOP1MT, and NTRK1

Al Assaf, C.;Lierman, E.;Devos, T.;Billiet, J.;Vandenberghe, P.;et.al.
(2014) British Journal of Haematology — Vol. 165, n° 5, p. 734-737 (2014)

Files

AlAssafCBrJHaematol2014.pdf
  • Restricted Access
  • Adobe PDF
  • 374.26 KB

Details

Authors
  • Al Assaf, C.
    Author
  • Lierman, E.
    Author
  • Devos, T.
    Author
  • Billiet, J.
    Author
  • Graux, CarlosUCLouvain
    Author
  • Vandenberghe, P.
    Author
Show more
Affiliations

Citations

Al Assaf, C., Lierman, E., Devos, T., Billiet, J., Graux, C., Papadopoulos, P., & Vandenberghe, P. (2014). Screening of JAK2 V617F and MPL W515 K/L negative essential thrombocythaemia patients for mutations in SESN2, DNAJC17, ST13, TOP1MT, and NTRK1. British Journal of Haematology, 165(5), 734-737. https://doi.org/10.1111/bjh.12790 (Original work published 2014)